Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Briacell Therapeutics Corp (BCTX)

Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference GlobeNewswire - Wed Mar 18, 6:30AM CDT

PHILADELPHIA and VANCOUVER, British Columbia, March 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting GlobeNewswire - Tue Mar 10, 6:30AM CDT

PHILADELPHIA and VANCOUVER, British Columbia, March 10, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting GlobeNewswire - Thu Mar 5, 3:04PM CST

PHILADELPHIA and VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX , BCTXL ) (TSX:BCT) (“BriaCell” or the “Company”) , a clinical-stage...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License GlobeNewswire - Wed Feb 18, 4:30PM CST

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“ BriaCell ”), a clinical-stage biotechnology...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer GlobeNewswire - Tue Feb 17, 6:30AM CST

Independent DSMB has identified no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor Fifth consecutive positive DSMB...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation GlobeNewswire - Wed Jan 28, 6:30AM CST

Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine lesions No Bria-IMT™ related discontinuations reported to date Bria-IMT...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients GlobeNewswire - Tue Jan 27, 6:30AM CST

9 of 25 BriaCell patients treated since 2022   remain alive >18-47 months post enrollment, markedly exceeding benchmarks reported for standard of care therapies in similar patient populations ...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
BriaCell Therapeutics Announces Closing of US$30 million Public Offering GlobeNewswire - Thu Jan 15, 3:05PM CST

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)
The $69B Precision Pivot: Why Biomarker Platforms are Igniting a New Oncology Gold Rush BayStreet.ca - Wed Jan 14, 8:56AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The genomics in cancer care market is on a massive tear, projected to hit $69.16 billion by 2032 as doctors...

ONCY : 0.8400 (-6.77%)
BCT.TO : 5.17 (-3.90%)
ACRV : 1.3300 (-6.34%)
LLY : 878.24 (-2.09%)
BCTX : 3.75 (-3.60%)
GLSI : 22.33 (-11.88%)
CATX : 4.07 (-3.55%)
BriaCell Therapeutics Announces Pricing of $30 million Public Offering GlobeNewswire - Tue Jan 13, 8:00PM CST

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 5.17 (-3.90%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.1300 (+14.04%)
BCTXL : 1.0000 (+7.53%)
BCTX : 3.75 (-3.60%)

Barchart Exclusives

Everyone Is Talking About Volatility. That’s Not The Story. Barchart - Sun Mar 29, 6:00PM CDT
Volatility isn’t the problem. The market is repricing flawed expectations, fragile ownership, and a structural shift investors haven’t caught up to yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.